The Plague Is Still With Us — And Could Return

The Disease That Refuses to Die

Most people think of the bubonic plague as a medieval horror story — something that belongs in the same category as leeches and flat-earth cartography. A catastrophe so thoroughly defeated by modern medicine that it barely warrants a footnote in contemporary public health discussions. That assumption is wrong, and dangerously so.

The plague is not a relic. It is an active, evolving pathogen that still infects people on multiple continents every year. In July 2025, a person in Arizona died from pneumonic plague — the most lethal of the disease's three forms. Madagascar, the Democratic Republic of the Congo, and Peru report cases annually. The United States averages roughly seven diagnoses per year. And underneath all of this sits a deeper, more unsettling truth: the biological and ecological conditions that once allowed plague to kill hundreds of millions of people have not been fully dismantled. They have merely gone quiet.

Understanding why the plague keeps coming back — and what would allow it to come back at scale — requires looking at both its ancient past and its very modern present.

What Actually Causes Bubonic Plague

For most of human history, plague was explained through theology, astrology, and fear. The actual cause, Yersinia pestis (Y. pestis), wasn't identified until 1894 — several centuries after Europe's most devastating outbreak had already killed tens of millions. This is worth pausing on: for roughly 1,300 years of recorded plague history, humanity had no idea what it was actually fighting.

Y. pestis is a bacterium, and it causes three distinct diseases depending on where it takes hold in the body. Bubonic plague, the most familiar form, infects the lymph nodes and produces the swollen, painful lumps called buboes. Septicemic plague enters the bloodstream and can cause tissue death severe enough to turn skin black. Pneumonic plague colonises the lungs and is transmissible through respiratory droplets — making it the most dangerous variant from a public health standpoint. Counterintuitively, the bubonic form is the most survivable of the three.

Modern antibiotics, when administered early enough, are effective against all three forms. The problem is that "early enough" often means within hours of symptom onset. Misdiagnosis is a genuine risk in regions where plague is rare and clinicians have little practical experience recognising it.

A Disease 5,000 Years in the Making

Recent ancient DNA research has dramatically expanded our understanding of how long Y. pestis has been infecting humans — and how it became the pandemic engine it is.

In 2021, researchers identified what is currently the oldest known plague case: a man who died in present-day Latvia more than 5,000 years ago. Ancient DNA recovered from his remains indicated the strain he carried was likely not highly contagious. He probably contracted it from a rodent bite and died within days from septicemic plague. A largely contained, tragic event.

But the bacteria didn't stay contained. By around 4,000 years ago, a strain known as the Late Neolithic Bronze Age (LNBA) lineage had spread across a vast swath of Eurasia — from Mongolia to Western Europe. How a pre-industrial pathogen managed to travel that distance remains partially unclear, but a 2025 study offered an important clue. Researchers found LNBA-era plague DNA in the bones of a domesticated sheep from the Eurasian steppes, genetically matched to human samples from the same region and era. The most likely scenario: the sheep encountered an infected wild animal, and the disease passed to humans during handling and consumption. Livestock, not fleas, may have been plague's original vector for human infection.

The flea-transmission pathway — the one most people associate with plague — came later. It depends on a gene called ymt, which helps Y. pestis survive inside a flea's digestive tract. Researchers have not found this mutation in samples older than 3,700 years, but it becomes ubiquitous in samples younger than 3,000 years. That single genetic acquisition transformed a regionally contained zoonotic disease into a potential pandemic pathogen.

Three Pandemics, One Bacterium

Y. pestis has been responsible for three confirmed plague pandemics, each separated by centuries but connected by a shared evolutionary lineage.

The first, the Plague of Justinian, began around 541 CE near Egypt and the Mediterranean. Named after the reigning Byzantine emperor, it is widely considered the first recorded pandemic in human history. Recent analysis of bacterial DNA extracted from teeth found in a Jordanian mass grave — published in 2025 — confirmed definitively that Y. pestis was the cause. The outbreak killed somewhere between 25 and 100 million people and triggered approximately 18 subsequent waves of infection before the strain eventually died out around the 8th century.

The second pandemic, anchored by the Black Death, began in 1346. For centuries, popular history blamed China as the origin point — a claim traceable not to scientific evidence but to a 14th-century poem about a fictional trickster spreading plague from China to the Mediterranean. The poet never intended it as history. Subsequent generations disagreed. A 2022 study using ancient genome analysis placed the actual origin in Central Asia. The Black Death killed at least one third of Europe's population. Its genetic shadow is still visible today: some of the protective gene variants that helped survivors resist the plague are now associated with elevated rates of autoimmune disorders, including Crohn's disease, in people of European descent.

The third pandemic emerged in Yunnan, China in the late 19th century and spread globally, causing around 12 million deaths over a century. One branch of the Black Death lineage eventually died out. The other became the evolutionary ancestor of every strain of plague circulating in the world today.

Why Plague Keeps Dying Out — And Why It Keeps Coming Back

There is a recurring pattern across all three pandemics: after roughly a century or two of devastation, the dominant Y. pestis strain appears to burn itself out. The leading explanation involves natural selection operating on the human population — individuals with genetic resistance survive in higher numbers, reproduce, and gradually increase population-wide immunity until the disease can no longer spread efficiently.

But a 2025 paper proposed a complementary mechanism operating on the bacteria itself. The study focused on a gene called pla, which helps Y. pestis evade immune detection long enough to reach the lymph nodes. More copies of pla make the bacterium more lethal — but so lethal that hosts die before they can infect others. Strains with fewer pla copies produce less severe disease, which paradoxically makes them evolutionarily fitter because their hosts survive longer and spread the infection further. This would explain why plague strains tend to become less deadly over time without disappearing entirely. The hypothesis remains contested, but it reframes Y. pestis not as a mindlessly destructive pathogen but as one subject to the same evolutionary trade-offs as any other organism.

The more troubling implication is this: if attenuation is a natural evolutionary trajectory, it can also reverse. A mutation that increases virulence without sacrificing transmissibility is not biologically impossible. It has happened before.

The Fourth Pandemic Risk Is Real

The reason a fourth plague pandemic remains a genuine scientific concern is not dramatic speculation — it is ecology.

Y. pestis does not need humans to survive. It maintains persistent reservoirs in wild animal populations, particularly rodents: prairie dogs, squirrels, chipmunks, and various species across Central Asia and sub-Saharan Africa. Fleas act as the bridge between these reservoirs and humans. But the bacterium's environmental reach extends further than most people realise. Research has confirmed that Y. pestis can persist in soil, survive in water-dwelling amoebas, and infect human body lice. Domestic cats are also susceptible to severe infection and, given their predatory habits, represent a plausible transmission pathway to human households in affected regions.

Climate change compounds the risk. Warmer temperatures expand the geographic range of flea populations. Shifts in precipitation affect rodent population dynamics. Increased human encroachment into previously wild habitats creates new interfaces between reservoir animals and people. These are not hypothetical pressures — they are already altering the distribution of vector-borne diseases globally.

The current toolkit for managing plague includes effective antibiotics (though resistant strains have already emerged), basic infection control measures including masks for pneumonic cases, and public health surveillance. What is notably absent is a widely available, effective, and affordable vaccine. Several candidates are in development, but the economics of vaccine manufacturing for a disease that currently infects fewer than 3,000 people per year globally make commercial investment difficult. That calculus would change rapidly in a pandemic scenario — but by then, the window for preparation would already have closed.

What This Means for the Rest of Us

None of this is cause for panic. Plague is not on the verge of a global comeback tomorrow. Antibiotic treatment, when delivered promptly, is highly effective. The infrastructure of modern public health — surveillance systems, rapid diagnostics, international disease reporting — is genuinely better equipped to detect and contain an emerging outbreak than anything available during the Black Death or the Plague of Justinian.

But complacency is its own risk. The history of Y. pestis is a history of a pathogen that repeatedly surprised the societies it encountered. It crossed continents before anyone understood how. It persisted in reservoirs that weren't identified for decades. It evolved its own virulence in ways researchers are still working to fully understand. And it did all of this while being dismissed, misidentified, or simply forgotten between outbreaks.

The most practical takeaways are straightforward: do not handle wild rodents, particularly in regions where plague is endemic or near-endemic. Treat flea infestations promptly, especially on pets with outdoor access. If you live in the American Southwest and develop sudden fever, swollen lymph nodes, and acute pain, tell your doctor immediately and mention the possibility of plague — not because it is likely, but because early diagnosis is the difference between recovery and a very different outcome. And if your cat drops a half-eaten squirrel at your feet, perhaps reconsider your level of concern.

The plague has outlasted every civilisation it has ever encountered. Respecting that track record is not alarmism. It is just good science.

Frequently Asked Questions

Is the bubonic plague still active in 2025?

Yes. The bubonic plague continues to infect people across multiple countries, including Madagascar, the Democratic Republic of the Congo, Peru, and the United States. In July 2025, a person in Arizona died from pneumonic plague, the most lethal form of the disease. Globally, cases remain relatively low — typically a few hundred to a few thousand per year — but the pathogen is far from extinct.

How do people contract plague today?

Most human plague cases today result from flea bites, typically from fleas that have fed on infected rodents such as prairie dogs, squirrels, or rats. Direct contact with infected animals — through handling, bites, or consumption — is also a transmission route. Pneumonic plague can spread between humans through respiratory droplets, though this is less common. Domestic cats that hunt wild rodents represent an underappreciated household risk in endemic areas.

Can antibiotics cure the plague?

Yes, when administered early. Several classes of antibiotics — including streptomycin, gentamicin, doxycycline, and ciprofloxacin — are effective against Y. pestis if treatment begins promptly after symptom onset. The critical challenge is speed: pneumonic plague in particular can be fatal within 24 to 72 hours without treatment. Some antibiotic-resistant strains have been identified, but they are not currently considered a widespread public health threat.

Why hasn't a plague vaccine been developed for widespread use?

Several plague vaccine candidates exist and have shown efficacy in trials, but none has been approved for broad public use. The core obstacle is economic and logistical: with only a few hundred to a few thousand cases reported globally per year, there is limited commercial incentive for pharmaceutical manufacturers to invest in large-scale production. Research continues, particularly focused on subunit vaccines that could be more easily manufactured at scale, but progress is slow. This gap in preparedness is a recognised concern among infectious disease researchers, particularly given the risk of a future pandemic.

What made the Black Death so catastrophic compared to modern plague outbreaks?

Several factors converged to make the Black Death uniquely devastating. Medieval populations had no prior immunity to the specific strain circulating, no understanding of germ theory, no antibiotics, and no public health infrastructure capable of containing spread. Fleas and rats moved freely through densely populated cities with poor sanitation. The pneumonic form, which can spread person-to-person, likely played a significant role in urban mortality. Modern medicine, improved sanitation, and global disease surveillance have dramatically reduced plague's ability to spread unchecked — but the ecological reservoirs that feed it remain intact.